Cetera Advisor Networks LLC Ionis Pharmaceuticals Inc Transaction History

Cetera Advisor Networks LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$43.39 - $51.63 $15,490 - $18,431	-357 Reduced 8.04%	4,081 $206,000
Q3 2023 Nov 14, 2023	SELL	$38.5 - $47.13 $28,374 - $34,734	-737 Reduced 14.24%	4,438 $201,000
Q2 2023 Aug 09, 2023	BUY	$34.73 - $43.33 $179,727 - $224,232	5,175 New	5,175 $212,000
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $210,544 - $263,861	5,672 New	5,672 $214,000
Q2 2022 Aug 11, 2022	BUY	$31.71 - $43.0 $41,064 - $55,685	1,295 Added 8.1%	17,276 $640,000
Q1 2022 May 12, 2022	BUY	$29.88 - $37.04 $94,301 - $116,898	3,156 Added 24.61%	15,981 $592,000
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $6,991 - $9,582	273 Added 2.17%	12,825 $390,000
Q3 2021 Nov 16, 2021	BUY	$33.54 - $40.55 $145,395 - $175,784	4,335 Added 52.76%	12,552 $421,000
Q2 2021 Aug 13, 2021	BUY	$34.54 - $47.25 $283,815 - $388,253	8,217 New	8,217 $328,000
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $13,665 - $18,129	-288 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $13,492 - $17,582	288 New	288 $17,000
Q2 2019 Aug 12, 2019	SELL	$62.09 - $86.14 $284,061 - $394,090	-4,575 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$52.92 - $81.17 $242,109 - $371,352	4,575 New	4,575 $366,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.